GED 0507-34-Levo

Overview

GED 0507-34-Levo is an orally active PPARγ modulator. GED 0507-34-Levo downregulates the expression of TGF-β , Smad3 , IL-13 , and CTGF in the colon. GED 0507-34-Levo improves DSS-induced chronic colitis and fibrosis.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > PPAR | Products > Signaling Pathways > TGF-beta/Smad

Product Information

• Catalog No.: HY-W109107
• CAS No.: 921195-93-9
• Molecular Formula: C10H13NO3
• Molecular Weight: 195.22
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source